Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo‐controlled, double‐blind, noninferiority study. J

Ulrike Blume-Peytavi, Zahida Issiakhem, Stephanie Gautier, J. Kottner, Walter Wigger-Alberti, Tobias Fischer, Rolf Hoffmann, Francoise Tonner, Athmane Bouroubi, Jean-Jacques Voisard

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Number of pages6
JournalJournal of Cosmetic Dermatology
Issue number18
DOIs
Publication statusPublished - 2019

Fields of science

  • 302087 Venereology
  • 302011 Dermatology

Cite this